Stock Deletions 02/22/2018
02/21/2018 XIV Credit Suisse
Stock Deletions 02/22/2018
02/21/2018 XIV Credit Suisse "Exchange Traded Fund" No Tier Deleted Event Acceleration ($5.99385666/sh). See press release dated 2/7/2018 by Credit Suisse.
02/21/2018 MYNG Advantego Corporation Common Stock Pink Current Deleted 1:11 R/S. See Daily List for additional information.
02/20/2018 UGYM US Guaranty of America, Inc. Common Stock Grey Market Deleted Inactive Security
02/20/2018 TSUAF Transeuro Energy Corp. Ordinary Shares Grey Market Deleted Inactive Security
02/20/2018 SGSUF Sangetsu Co., Ltd. Ordinary Shares Grey Market Deleted Inactive Security
02/20/2018 LHTCF Launch Tech Company Ltd. Ordinary Shares Grey Market Deleted Inactive Security
02/20/2018 GQMRF Golden Queen Mining Co. Ltd. Rights Pink Current Deleted Matured/Expired
02/20/2018 DRMMF Dream International Ltd. Ordinary Shares Pink Current Reactivated
02/20/2018 DEL Deltic Timber Corp. Common Stock No Tier Deleted Merger
02/20/2018 CINWF Cineworld Group PLC Rights Grey Market Deleted Matured/Expired
02/20/2018 BSSOF Basso Industry Corp. Ordinary Shares Grey Market Deleted Inactive Security
02/19/2018 TAPCF Tai Ping Carpets International Ordinary Shares Pink Current Reactivated
02/19/2018 SVPLF St. Ives Plc Ordinary Shares Pink Current Reactivated
02/19/2018 STCB Starco Brands, Inc. Common Stock OTCQB Deleted 1:30 R/S
02/19/2018 SB.PRBCL Safe Bulkers, Inc. Preferred Stock No Tier Deleted Fully called.
02/19/2018 PRDZF Promotora De Informaciones SA Rights Pink Current Deleted Matured/Expired
02/19/2018 OSTLY ACN 004 410 833 Ltd. American Depository Receipts Pink Current Deleted ADR/GDR Program Terminated
02/19/2018 EWCR Empire Water Corp. Common Stock Pink No Information Deleted "Charter Cancelled/Dissolution Company Dissolved. Shares Cancelled."
02/19/2018 DTK.CL Deutsche Bank Contingent Capital Trust III Preferred Stock No Tier Deleted Fully called.
02/15/2018 SCGGF Shougang Concord Grand Group Ltd. Ordinary Shares Grey Market Deleted Inactive Security
02/15/2018 MTFSF Metalfrio Solutions SA Ordinary Shares Grey Market Reactivated
02/15/2018 MBVX MabVax Therapeutics Holdings, Inc. Common Stock No Tier Deleted "1 3 R/S"
02/15/2018 LSCG Lighting Science Group Corp. Common Stock Pink No Information Deleted "1:10000 R/S Followed by 10000:1 F/S Shareholders of less than 10,000 shares will received $0.04 for each pre split share. Shareholders of 10,000 or more shares will not be affected by this corporate action."
02/15/2018 HNNYY Hanny Holdings Ltd. American Depository Receipts Grey Market Deleted ADR/GDR Program Terminated
02/15/2018 DPRTF Dip Corp. Ordinary Shares Grey Market Reactivated
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...
Continue Reading
Raytron's Market Supremacy: By the Numbers If you're looking at the thermal imaging sector and wondering what's what, take a clue from Raytron. This outfit isn't just playing the game—it's running the show with a staggering 30% of the global market in 2025. That's right, they hold the medal for leading global shipments in thermal imaging, and unlike many industries...
Continue Reading
Asphalt Additives: A Lucrative Growth Path Let me tell you, the asphalt additives market isn't just sticking to the roads; it's rolling out real potential. Heading for a $7.07B finish line by 2031 with a steady pace of 7.3% CAGR, it's a road worth staking your claims on. The underlying story? It's more than just laying tar. Pavement to Profit: Key Drivers The asphalt...
Continue Reading
NACD Recognition for Governance Grit Some folks just know how to steer a ship, and that's exactly what Pearl Meyer's Matt Turner and Jannice Koors have been doing. This year, they made it onto the NACD's 2026 Directorship 100 list, swinging as heavy hitters in the Governance Professionals category. It's not just another day at the office when you're honored by the...
Continue Reading
Diving Headfirst into Holiday Tech Splurging The holiday hustle is upon us, folks, and Epson's stepping up with early Black Friday deals that'll have tech heads scrambling. They’re cutting prices up to $250 on their swanky home lineup—projectors, printers, scanners, you name it. This ain't just about making someone else smile, though; it's about the sweet spot where...
Continue Reading
The Truth Behind Doximity's Promises The brass tacks of investing often boil down to trust—a commodity that's now in short supply over at Doximity, Inc. (NYSE: DOCS). Investors have been left hanging after promises of lucrative engagement signals turned out to be a mere pipe dream. Levi & Korsinsky, LLP sounds the alarm on what's shaping up to be a high-stakes class...
Continue Reading
When's the last time you saw a medical device market promising a $10 billion leap in under five years? Yeah, the insulin delivery devices market's got that kind of upside, projected to skyrocket from $16.92 billion in 2026 to a whopping $26.37 billion by 2031. That's a 9.3% annual growth rate. The numbers and the stakes are both staggering. Regional and Segment Leaders...
Continue Reading
A Nutty Approach to Diabetes Prevention Who would've thought peanuts could pack such a punch against diabetes? Amid the usual suspects of healthy foods, it's these humble legumes that are making headlines. The Peanut Institute, backed by fresh research, is shining a spotlight on their potential role in preventing type 2 diabetes, a disease that's affecting roughly 40...
Continue Reading
A New Giant in California's Solar Landscape Out in California's desert, Terra-Gen has flipped the switch on something pretty colossal: the $950 million Lockhart Solar and Storage Project. Picture this—a solar beast boasting 538.7 MW of capacity, primed to light up around 350,000 homes and businesses. That's not just flipping a light switch; that's sparking a fire that...
Continue Reading
The Big Names Hold Steady Defense contractors are showing off their shiny earnings just as some disturbing headlines shake things up. It's like they're putting their best foot forward to steady the ship while the waters get choppy with terrorism charges and all sorts of geopolitical noise. Follow the smart money to see where the true bets are being placed—it all unfolds...
Continue Reading
Top 5 Most Recently Viewed Articles
Twilio Inc Fourth Quarter Overview Twilio Inc reported notable financial results for the fourth quarter, capturing the attention of several analysts within the market. The company’s performance has sparked diverse reactions, particularly regarding its future guidance and the evolving role of artificial intelligence within its operations. Market Response to Q4 Earnings...
Continue Reading
FHLBank Indianapolis Declares Second Quarter Dividends FHLBank Indianapolis recently announced its second quarter dividends for 2025, detailing robust financial strategies and growth, as reflected in the declared dividends on Class B-2 activity-based capital stock and Class B-1 non-activity-based stock. These dividends have been set at annualized rates of 9.50% and 4.50%,...
Continue Reading
Revolutionizing Alzheimer's Detection with Neurogen Biomarking Neurogen Biomarking is making significant strides in the healthcare landscape by introducing a pioneering blood test aimed at the early detection of Alzheimer's disease and Mild Cognitive Impairment (MCI). This innovative approach leverages advanced biomarker technology developed by Quanterix Corporation,...
Continue Reading
Revolutionizing Industries with the K2 Bumblebee Shanghai Kepler Robotics Co., Ltd has excitedly announced the commencement of mass production of its K2 "Bumblebee" model, confirming that the world's first commercially available hybrid-architecture humanoid robot is now shipping to eager customers. Milestone in Humanoid Robotics This significant development not only marks...
Continue Reading
Positive Interim Data from Syntara's Clinical Trials Syntara Limited, known for its innovative approach in drug development, has unveiled promising interim data concerning its ongoing Phase 2 study of SNT-5505. This clinical trial focuses on myelofibrosis, a complex bone marrow disorder that often leads to severe health complications. Details of the Clinical Trial The...
Continue Reading